Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen K Lennerz

Oncotarget

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncotarget|January 18, 2015
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinomaFenja M Feld, Philipp D Nagel, Stephanie E Weissinger, et al.
Oncotarget|September 5, 2015
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphomaJochen K Lennerz, Karl Hoffmann, Anna-Maria Bubolz, et al.
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Oncotarget|July 16, 2013
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)Olga Ritz, Karolin Rommel, Karola Dorsch, et al.
Oncotarget|November 18, 2014
The landscape of metastatic progression patterns across major human cancersJan Budczies, Moritz von Winterfeld, Frederick Klauschen, et al.
Oncotarget|August 14, 2014
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasmAlbrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.
Oncotarget|June 19, 2014
Potential clinical implications of BRAF mutations in histiocytic proliferationsAnna-Maria Bubolz, Stephanie E Weissinger, Albrecht Stenzinger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncotarget|January 18, 2015
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinomaFenja M Feld, Philipp D Nagel, Stephanie E Weissinger, et al.
Oncotarget|September 5, 2015
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphomaJochen K Lennerz, Karl Hoffmann, Anna-Maria Bubolz, et al.
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Oncotarget|July 16, 2013
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)Olga Ritz, Karolin Rommel, Karola Dorsch, et al.
Oncotarget|November 18, 2014
The landscape of metastatic progression patterns across major human cancersJan Budczies, Moritz von Winterfeld, Frederick Klauschen, et al.
Oncotarget|August 14, 2014
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasmAlbrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.
Oncotarget|June 19, 2014
Potential clinical implications of BRAF mutations in histiocytic proliferationsAnna-Maria Bubolz, Stephanie E Weissinger, Albrecht Stenzinger, et al.
Pageof 1